Get started
Author

Xiuqin Li

The First Approved Gene Therapy Product for Cancer Ad- p53 (Gendicine): 12 Years in the Clinic
2018 · Wei-Wei Zhang, Longjiang Li, et al. · Human Gene Therapy · 337
Rapamycin alleviates cognitive impairment in murine vascular dementia: The enhancement of mitophagy by PI3K/AKT/mTOR axis
2020 · Guimin Zheng, Lei Wang, et al. · Tissue and Cell · 54
Association between pre-diagnostic dietary pattern and survival of ovarian cancer: Evidence from a prospective cohort study
2021 · Zhao-Yan Wen, Chuan Liu, et al. · Clinical Nutrition · 35
Identification of an energy metabolism‑related gene signature in ovarian cancer prognosis
2020 · Lei Wang, Xiuqin Li · Oncology Reports · 33
PDF
Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study of TP53 Gene Therapy
2017 · Yu Xia, Zhenhua Du, et al. · Human Gene Therapy · 33
Expert consensus on the clinical application of recombinant adenovirus human p53 for head and neck cancers
2021 · Yi Li, Wei Guo, et al. · International Journal of Oral Science · 26
PDF
Proteomic identification of tumor-associated protein in ovarian serous cystadenocarinoma
2008 · Xiu-Qin Li, Shu-Lan Zhang, et al. · Cancer Letters · 20
Comprehensive genomic profiling of high‐grade serous ovarian carcinoma from Chinese patients identifies co‐occurring mutations in the Ras/Raf pathway with TP53
2019 · Fangfang Zhong, Tao Zhu, et al. · Cancer Medicine · 19
PDF
Regulatory role of microRNA-30b and plasminogen activator inhibitor-1 in the pathogenesis of cognitive impairment
2016 · XIUQIN LI, YONG GAO, et al. · Experimental and Therapeutic Medicine · 12
PDF
Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer
2020 · Hui Qu, Yu Xia, et al. · Current Gene Therapy · 8
Novo pathogenic variations of NLRP7 increasing the risk of gestational trophoblastic neoplasia
2022 · Chengqiu Tao, Tingting Zhu, et al. · Clinical Genetics · 6
Investigation on the Genomic Characterization of Uterine Sarcoma for rAd- p53 Combined with Chemotherapy Treatment
2020 · Yu Xia, Lei Wang, et al. · Human Gene Therapy · 6
Whole-exome sequencing reveals genetic variants in ERC1 and KCNG4 associated with complete hydatidiform mole in Chinese Han women
2017 · Yan Yu, Bingjian Lu, et al. · Oncotarget · 5
PDF
EGb761 suppressed vascular dementia via modulating Wnt/β-catenin signaling pathway-induced apoptosis and autophagy in hippocampal neuronal cells
2025 · Nan Yin, Zhipeng Tang, et al. · European journal of medical research · 3
PDF
Effect of activin A on OVCAR-3 Ovarian epithelial cancer cells
2008 · Xiu-qin Li, Bo Ren, et al. · Chinese Journal of Cancer Research · 2
Reflections on the changes in ascites and serum VEGF1 levels before and after intraperitoneal infusion of bevacizumab.
2024 · Zhenhua Du, Yu Xia, et al. · Journal of Clinical Oncology
PDF
Evaluation of therapeutic efficiency about the combination therapy of rAd-p53 with chemotherapy for the treatment of recurrent uterine sarcomas.
2015 · Xia Yu, Xinyan Wang, et al. · Journal of Clinical Oncology
Field Trial of Six Fungicides Controlling the Apple Scab
2011 · Xiuqin Li · Modern Agrochemicals
Deepening Teaching Reform in Colleges and Cultivating Innovative Talents——An Analysis Based on the Literature
2008 · Xiuqin Li · Journal of Technology College Education
Study on the Niche of Dominant Species in Evergreen Broadleaved Forest in Linnan Nature Reserve
2007 · Xiuqin Li · Nanjing Linye Daxue xuebao
A Preliminary Study on Beam of Aged Patients With Chronic Schizophrenia
2002 · Zhong Wenbing, Xiuqin Li, et al.
Research of the Humanistic Education in the Chemistry Major of Normal Universities
2001 · Xiuqin Li · Journal of Heze Teachers College
Works count: 22
Citation count: 599
H-index: 9
I10-index: 9
Year
Topic
Type